OTC · CIK 0001413119
KBLB Kraig Biocraft Laboratories, Inc.
Insider trading from SEC Form 4. Last filing May 29, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at Kraig Biocraft Laboratories, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2025 | Jonathan Richard Rice Chief Operating Officer | XIn-the-money exercise Class A Common Stock | +314,636 | $0.08 | $26k | 5,692,836 | May 29, 2025 |
| May 27, 2025 | Jonathan Richard Rice Chief Operating Officer | XIn-the-money exercise Class A Common Stock Warrantderivative | -318,482 | - | - | 0 | May 29, 2025 |
| Mar 31, 2025 | Kimberly Kraig Thompson Chief Executive Officer | WWill or inheritance Common Stock | +27,500 | $0.09 | $2,492 | 201,677,922 | Apr 10, 2025 |
| Mar 31, 2025 | Kimberly Kraig Thompson Chief Executive Officer | WWill or inheritance Common Stock | +62,500 | $0.09 | $5,663 | 201,650,422 | Apr 8, 2025 |
| Dec 4, 2024 | Jonathan Richard Rice Chief Operating Officer | XIn-the-money exercise Class A Common Stock Optionderivative | +1,112,000 | - | - | 4,320,121 | Mar 24, 2025 |
| Jan 15, 2025 | Jonathan Richard Rice Chief Operating Officer | XIn-the-money exercise Class A Common Stock Optionsderivative | +181,518 | - | - | 4,499,698 | Mar 24, 2025 |
| Jan 15, 2025 | Jonathan Richard Rice Chief Operating Officer | XIn-the-money exercise Class A Common Stock Optionsderivative | +888,000 | - | - | 5,378,201 | Mar 24, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Jonathan Richard RiceChief Operating Officer
- Kimberly Kraig ThompsonChief Executive Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.